Tudor Investment Corp
GBT

Tudor Investment Corp’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Tudor Investment Corp’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-250,091
Closed -$17M – 3041
2022
Q3 		$17M Buy
250,091
+203,528
+437% +$11.2M 0.37% 27
2022
Q2 		$1.49M Buy
46,563
+33,536
+257% +$982K 0.04% 657
2022
Q1 		$451K Sell
13,027
-44,919
-78% -$1.34M 0.01% 1328
2021
Q4 		$1.7M Sell
57,946
-30,390
-34% -$941K 0.03% 725
2021
Q3 		$2.25M Buy
+88,336
New +$2.6M 0.04% 640
2018
Q2 		– Sell
-5,990
Closed -$289K – 1286
2018
Q1 		$289K Sell
5,990
-2,575
-30% -$144K 0.01% 754
2017
Q4 		$337K Sell
8,565
-825
-9% -$30.8K 0.01% 769
2017
Q3 		$292K Sell
9,390
-12,315
-57% -$346K 0.01% 838
2017
Q2 		$594K Buy
+21,705
New +$646K 0.02% 511
2016
Q3 		– Sell
-26,243
Closed -$435K – 1806
2016
Q2 		$435K Buy
+26,243
New +$529K 0.01% 935
2015
Q4 		– Sell
-8,200
Closed -$346K – 1898
2015
Q3 		$346K Buy
+8,200
New +$387K 0.01% 1003

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tudor Investment Corp's GBT Position: Q4 2022 in Review

Tudor Investment Corp sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 250,091 shares — an estimated $17M sold.

Tudor Investment Corp first reported a position in GBT in Q3 2015 and held it in 11 quarters. The position peaked at $17M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Tudor Investment Corp reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 250,091 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $17M.
  • Tudor Investment Corp first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 11 quarters.
  • Tudor Investment Corp's Global Blood Therapeutics, Inc. position peaked at $17M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.